Stocks and Investing Stocks and Investing
Fri, October 14, 2022

Do Kim Maintained (TVTX) at Buy with Decreased Target to $38 on, Oct 14th, 2022


Published on 2024-10-27 23:23:02 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Decreased Target from $39 to $38 on, Oct 14th, 2022.

Do has made no other calls on TVTX in the last 4 months.



There are 3 other peers that have a rating on TVTX. Out of the 3 peers that are also analyzing TVTX, 0 agree with Do's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Do


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $42 on, Monday, August 8th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $45 on, Friday, August 5th, 2022
  • Edward Nash of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $42 on, Thursday, July 14th, 2022
Contributing Sources